IRIS
PONZANO, MARTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.828
AS - Asia 41
SA - Sud America 13
AF - Africa 1
Totale 3.883
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 3.828
CN - Cina 26
BR - Brasile 12
VN - Vietnam 8
SG - Singapore 5
BD - Bangladesh 1
ID - Indonesia 1
MA - Marocco 1
PY - Paraguay 1
Totale 3.883
Salva come PNG Salva come JPEG
Città #
Genoa 2.564
Vado Ligure 621
Rapallo 373
Genova 246
Bordighera 22
Beijing 11
Singapore 4
Haiphong 2
Ho Chi Minh City 2
Araçoiaba da Serra 1
Asunción 1
Bạc Liêu 1
Bắc Ninh 1
Curitiba 1
Joinville 1
Marília 1
Novo Hamburgo 1
Passa Quatro 1
Rio de Janeiro 1
Salvador 1
Sorocaba 1
São Carlos 1
São Paulo 1
Thái Nguyên 1
Venda Nova do Imigrante 1
Totale 3.861
Salva come PNG Salva come JPEG
Nome #
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients 160
Impact of tDCS on persistent COVID-19 olfactory dysfunction: a double-blind sham-controlled study 142
The prognostic role of baseline metabolic tumor burden and systemic inflammation biomarkers in metastatic castration-resistant prostate cancer patients treated with Radium-223: A proof of concept study 134
Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis 99
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis 93
597P Endometrial carcinoma and mismatch repair deficiency: Clinical association and universal screening for Lynch syndrome 91
Cervical musculoskeletal impairments in the 4 phases of the migraine cycle in episodic migraine patients 90
Aromatase inhibitor-induced bone loss osteosarcopenia in older patients with breast cancer: effects of the RANK/RANKL system’s inhibitor denosumab vs. bisphosphonates 87
Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational Study 85
High-resolution Doppler ultrasound in systemic sclerosis: Analysis of digital arteries and nailfold microvasculature using 18-5 MHz and 33-9 MHz probes 84
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 83
Multiple Sclerosis: insights on COVID-19, treatments and inequalities 81
The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study) 79
Disability, burden, and symptoms related to sensitization in migraine patients associate with headache frequency 76
Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease 75
Quality of life and upper limb disability in Charcot-Marie-Tooth disease: A pilot study 74
Effect of SARS-CoV-2 vaccination in a vulnerable COVID-19 cohort: a real-life experience in an Italian Hospital 69
Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 Vaccination 69
Prognostic Value of the BIO-Ra Score in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223 after the European Medicines Agency Restricted Use: Secondary Investigations of the Multicentric BIO-Ra Study 69
Reliability of patient-reported toxicities during adjuvant chemotherapy 66
Measuring calf circumference in frail hospitalized older adults and prediction of in-hospital complications and post-discharge mortality 64
1942. Effect of {SARS}-{CoV}-2 Vaccination in a Frailty {COVID}-19 Cohort: a Real Life Experience in a Northern Italy Hospital 64
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting? 64
Coronavirus disease 2019 in Latin American patients with multiple sclerosis 64
Dietary antioxidants, non-enzymatic antioxidant capacity and the risk of osteoarthritis in the Swedish National March Cohort 62
A novel immunotherapy prognostic score for patients with pretreated advanced urInary TrAct CArcinoma from the subgroup analysis of the SAUL study: the ITACA Score 61
Compressed sensing (CS) MP2RAGE versus standard MPRAGE: A comparison of derived brain volume measurements 56
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab 56
Digital work engagement among Italian neurologists 52
Development and initial validation of the ONCOREUM score to differentiate childhood cancer with arthropathy from juvenile idiopathic arthritis 52
Systemic therapy for pre-treated malignant mesothelioma: A systematic review, meta-analysis and network meta-analysis of randomised controlled trials 51
Renal function assessment in older people: comparative analysis of estimation equation with serum creatinine 51
Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surge 48
Assessing the duration of EDSS improvement after a therapy start: A novel approach applied to the long-term extension of the PRISMS study 48
Increase pain sensitivity during the four phases of the migraine cycle in patients with episodic migraine 47
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 47
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study 46
Prognostic Frailty-Based Determinants of Long-Term Mortality in Older Patients with Newly Diagnosed Multiple Myeloma 45
The MuSC-19 study: The Egyptian cohort 45
Patient’s point of view on the use of telemedicine in multiple sclerosis: a web-based survey 45
Composite Prediction Score to Interpret Bone Focal Uptake in Hormone-Sensitive Prostate Cancer Patients Imaged with [18F]PSMA-1007 PET/CT 44
What happens after fingolimod discontinuation? A multicentre real-life experience 44
Blood-brain barrier damage associates with glia-related cytokines in the cerebrospinal fluid of patients with Multiple Sclerosis 44
Profiling migraine patients according to clinical and psychophysical characteristics: a cluster analysis approach 42
Not all Forms of Muscle Hypertonia Worsen With Fatigue: A Pilot Study in Para Swimmers 42
Extra-prostatic extension grading system: correlation with MRI features and integration of capsular enhancement sign for “enhanced” detection of T3a lesions 39
Reply to “Cognition and motor phenotypes in ALS: a retrospective study” 39
Useful outcome measures in INPH patients evaluation 37
Trigeminocervical pain sensitivity during the migraine cycle depends on headache frequency 37
Migraine patients with and without neck pain: Differences in clinical characteristics, sensitization, musculoskeletal impairments, and psychological burden 35
Clinical and Ultrasound Evaluation of Hemiplegic Shoulder Pain in Stroke Patients: A Longitudinal Observational Study Starting in the First Hours After Stroke 35
One-year follow-up comparison of two hybrid closed-loop systems in Italian children and adults with type 1 diabetes 35
Creating an automated tool for a consistent and repeatable evaluation of disability progression in clinical studies for multiple sclerosis 34
Tipping the Balance Between Cognitive Reserve, Frailty, and Dementia in the Very Old? 33
Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis 33
Psychological resilience is protective against cognitive deterioration in motor neuron diseases 32
Urinary phthalate and DINCH metabolite concentrations and gradations of maternal glucose intolerance 32
COVID-19 vaccine hesitancy among Italian people with multiple sclerosis 31
Single-Port Cholecystectomy for Cholecystitis Versus Non-Cholecystitis 31
Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: an application using data from the MSBase Registry 30
Retinal Hyperreflecting Foci Associate With Cortical Pathology in Multiple Sclerosis 30
Hyper-reflective foci changes in RRMS under natalizumab therapy 28
High NEDA and No PIRA in Natalizumab-Treated Patients With Pediatric-Onset Multiple Sclerosis 27
Profiling migraine patients according to clinical and psychophysical characteristics: clinical validity of distinct migraine clusters 27
Therapeutic lag: Is treatment effect delayed in progressive MS? 26
Management of the Medico-Legal Dispute of Healthcare-Related SARS-CoV-2 Infections: Evaluation Criteria and Case Study in a Large University Hospital in Northwest Italy from 2020 to 2021 26
Ideal cardiovascular health and risk of death in a large Swedish cohort 26
Trigeminal and cervical sensitization during the four phases of the migraine cycle in patients with episodic migraine 26
Severe outcomes of COVID-19 among patients with multiple sclerosis under anti-CD-20 therapies: A systematic review and meta-analysis 25
Race and ethnicity in multiple sclerosis phase 3 clinical trials: A systematic review 24
Prevalence of disability improvement in relapsing‐remitting multiple sclerosis patients treated with cladribine tablets 24
Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study 21
Uncovering a bias in estimated treatment effects on PIRA in multiple sclerosis clinical trials 14
Improved Measurement of Treatment Effect in Multiple Sclerosis Clinical Trials 14
Signs and symptoms of Covid-19 in patients with multiple sclerosis 14
Treatment Effect on Brain Atrophy Correlates with Treatment Effect on Cognition in Multiple Sclerosis 13
Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis 12
Mild behavioral impairment as a potential marker of predementia risk states in motor neuron diseases 11
Reinterpreting Clinical Trials in Children With Multiple Sclerosis Using a Bayesian Approach 7
Beyond traditional proxies: the contribution of leisure to cognitive reserve and dementia 7
Predictors for choosing doravirine‐based versus INSTI‐based regimen in ART‐naïve and ART‐experienced people with HIV in real‐world setting: Data from the Icona cohort 5
Complex methods for complex data: key considerations for interpretable and actionable results in exposome research 5
Is gaitrite system sensitive in discriminating gait pattern of subjects affected by Charcot Marie tooth? A pilot study 4
BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party 4
Social determinants of health in multiple sclerosis in Italy: A scoping review 4
Dietary non-enzymatic antioxidant capacity and risk of breast cancer: the Swedish National March Cohort 3
Predictive factors for therapeutic response and cluster analysis in syndrome of undifferentiated recurrent fever (SURF) 1
Totale 4.031
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.319
article - articoli 20.191
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.510
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202179 0 0 0 0 18 38 1 10 4 4 2 2
2021/2022164 1 0 6 7 5 5 5 29 17 23 3 63
2022/2023456 28 29 11 40 77 55 11 42 67 14 67 15
2023/2024454 19 38 4 53 38 90 33 34 16 29 33 67
2024/20251.717 83 99 54 122 182 203 154 264 88 104 163 201
2025/20261.130 400 166 297 267 0 0 0 0 0 0 0 0
Totale 4.031